Free iron, total F2-isoprostanes and total F4- neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: Neuroprotective effect of melatonin

Journal of Pineal Research

Volumn 46, Issue 2, 2009, Pages 148-154

  Signorini, Cinzia ^a   Ciccoli, Lucia ^a   Leoncini, Silvia ^a   Carloni, Silvia ^b   Perrone, Serafina ^a   Comporti, Mario ^a   Balduini, Walter ^b   Buonocore, Giuseppe ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

Author keywords

Free iron; Hypoxia ischemia; Melatonin; Neuroprostanes; Neuroprotection; Newborn rats; Oxidative stress

Indexed keywords

ARACHIDONIC ACID; DEFEROXAMINE; DOCOSAHEXAENOIC ACID; F4 NEUROPROSTANE DERIVATIVE; FREE RADICAL; ISOPROSTANE DERIVATIVE; MELATONIN; NITROGEN; OXYGEN; PROSTANOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CAROTID ARTERY LIGATION; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; HYPOXIA; LIPID PEROXIDATION; NEUROPROTECTION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; F2-ISOPROSTANES; HYPOXIA, BRAIN; IRON; MELATONIN; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; RATS;

EID: 59149103504     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00639.x     Document Type: Article

References (66)

1. Aggarwal R, Deodari AK, Paul VK. Post-resuscitation management of asphyxiated neonates. Indian J Pediatr 2001 68 : 1149 1153.
2. Buonocore G, Perrone S, Longini M, Terzuoli L, Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 2000 47 : 221 224.
3. Buonocore G, Perrone S, Longini M et al. Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr Res 2002 52 : 46 49.
4. Goplerud JM, Mishra OP, Delivoria-Papadopoulos M. Brain cell membrane dysfunction following acute asphyxia in newborn piglets. Biol Neonate 1992 61 : 33 41.
5. Sorg O, Horn TF, Yu N, Gruol DL, Bloom FE. Inhibition of astrocyte glutamate uptake by reactive oxygen species: role of antioxidant enzymes. Mol Med 1997 3 : 431 440.
6. Palmer C, Menzies SL, Roberts RL, Pavlick G, Connor Jr. Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res 1999 56 : 60 71.
7. Gitto E, Reiter RJ, Karbownik M et al. Causes of oxidative stress in the pre- and perinatal period. Biol Neonate 2002 81 : 146 157.
8. Bracci R, Perrone S, Buonocore G. The timing of neonatal brain damage. Biol Neonate 2006 90 : 145 155.
9. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 2nd edn. Clarendon Press, Oxford, 1989.
10. Allen DR, Wallis GL, Mccay PB. Catechol adrenergic agents enhance hydroxyl radical generation in xanthine oxidase systems containing ferritin: implications for ischemia/reperfusion. Arch Biochem Biophys 1994 315 : 235 243.
11. Vexler ZS, Ferriero DM. Molecular and biochemical mechanisms of perinatal brain injury. Semin Neonatol 2001 6 : 99 108.
12. Buonocore G, Perrone S, Bracci R. Free radicals and brain damage in the newborn. Biol Neonate 2001 79 : 180 186.
13. Selim MH, Ratan RR. The role of iron neurotoxicity in ischemic stroke. Ageing Res Rev 2004 3 : 345 353.
14. Fulia F, Gitto E, Cuzzocrea S et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001 31 : 343 349.
15. Buonocore G, Perrone S, Longini M et al. Non protein bound iron as early predictive marker of neonatal brain damage. Brain 2003 126 : 1224 1230.
16. Shadid M, Buonocore G, Groenendaal F et al. Effect of deferoxamine and allopurinol on non-protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia. Neurosci Lett 1998 248 : 5 8.
17. Montuschi P, Barnes PJ, Roberts LJ II. Isoprostanes: markers and mediators of oxidative stress. FASEB J 2004 18 : 1791 1800.
18. Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ II. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A 1992 89 : 10721 10725.
19. Roberts LJ II., Morrow JD. Measurement of isoprostanes to asses oxidant stress status in vivo. In : Free Radicals in Chemistry, Biology and Medicine. Yoshikawa T, Toyokuni S, Yamamoto Y, Naito Y, eds. OICA International, London, 2000 pp. 329 340.
20. Comporti M, Signorini C, Leoncini S, Buonocore G, Rossi V, Ciccoli L. Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med 2004 37 : 724 732.
21. Signorini C, Perrone S, Sgherri C et al. Plasma esterified F2-isoprostanes and oxidative stress in newborns: role of nonprotein-bound iron. Pediatr Res 2008 63 : 287 291.
22. Longini M, Perrone S, Kenanidis A et al. Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. Free Radic Biol Med 2005 38 : 1537 1541.
23. Söderberg M, Edlund C, Kristensson K, Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991 26 : 421 425.
24. Nourooz-Zadeh J, Liu EH, Yhlen B, Anggard EE, Halliwelli B. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J Neurochem 1999 72 : 734 740.
25. Roberts LJ II., Montine TJ, Markesbery WR et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 1998 273 : 13605 13612.
26. Maldonado MD, Murillo-Cabezas F, Terron MP et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res 2007 42 : 1 11.
27. Tan DX, Reiter RJ, Manchester LC et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002 2 : 181 197.
28. Rosen J, Than NN, Koch D, Poeggeler B, Laatsch H, Hardeland R. Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 2006 41 : 374 381.
29. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
30. Shida CS, Castrucci AM, Lamy-Freund MT. High melatonin solubility in aqueous medium. J Pineal Res 1994 16 : 198 201.
31. Jou MJ, Peng TI, Yu PZ et al. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res 2007 43 : 389 403.
32. Costa EJ, Shida CS, Biaggi MH, Ito AS, Lamy-Freund MT. How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies. FEBS Lett 1997 416 : 103 106.
33. Ceraulo L, Ferrugia M, Tesoriere L, Segreto S, Livrea MA, Turco Liveri V. Interactions of melatonin with membrane models: portioning of melatonin in AOT and lecithin reversed micelles. J Pineal Res 1999 26 : 108 112.
34. Barlow-Walden LR, Reiter RJ, Abe M et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995 26 : 497 502.
35. Pablos MI, Reiter RJ, Ortiz GG et al. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem Int 1998 32 : 69 75.
36. Antolin I, Rodriguez C, Sainz RM et al. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 1996 10 : 882 890.
37. Tomas-Zapico C, Coto-Montes A, Martinez-Fraga J, Rodriguez-Colunga MJ, Hardeland R, Tolivia D. Effects of delta-aminolevulinic acid and melatonin in the Harderian gland of female Syrian hamsters. Free Radic Biol Med 2002 32 : 1197 1204.
38. Rodriguez C, Mayo JC, Sainz RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
39. Cheung RT. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003 34 : 153 160.
40. Pei Z, Pang SF, Cheung RT. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke 2003 34 : 770 775.
41. Koh PO. Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3. J Pineal Res 2008 44 : 101 106.
42. Carloni S, Perrone S, Buonocore G, Longini M, Proietti F, Balduini W. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 2008 44 : 157 164.
43. Signorini C, Comporti M, Giorgi G. Ion trap tandem mass spectrometric determination of F2-isoprostanes. J Mass Spectrom 2003 38 : 1067 1074.
44. Nourooz-Zadeh J, Liu EH, Anggård E, Halliwell B. F4-isoprostanes: a novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA). Biochem Biophys Res Commun 1998 242 : 338 344.
45. Garcia JJ, Reiter RJ, Pie J et al. Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress. J Bioenerg Biomembr 1999 31 : 609 616.
46. Tanaka E, Niiyama S, Sato S, Yamada A, Higashi H. Arachidonic acid metabolites contribute to the irreversible depolarization induced by in vitro ischemia. J Neurophysiol 2003 90 : 3213 3223.
47. Montine TJ, Montine KS, Reich EE, Terry ES, Porter NA, Morrow JD. Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes. Biochem Pharmacol 2003 65 : 611 617.
48. Takahashi K, Nammour TM, Fukunaga M et al. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest 1992 90 : 136 141.
49. Kang KH, Morrow JD, Roberts LJ II., Newman JH, Banerjee M. Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lung. J Appl Physiol 1993 74 : 460 465.
50. Hoffman SW, Moore S, Ellis EF. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke 1997 28 : 844 849.
51. Lahaie I, Hardy P, Hou X et al. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am J Physiol 1998 274 : R1406 R1416.
52. Hou X, Gobeil F Jr., Peri K et al. Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels. Stroke 2000 31 : 516 525.
53. Brault S, Martinez-Bermudez AK, Marrache AM et al. Selective neuromicrovascular endothelial cell death by 8-Iso-prostaglandin F2alpha: possible role in ischemic brain injury. Stroke 2003 34 : 776 782.
54. Papazisis G, Pourzitaki C, Sardeli C, Lallas A, Amaniti E, Kouvelas D. Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia. Pharmacol Res 2008 57 : 73 78.
55. Ferrali M, Signorini C, Ciccoli L, Comporti M. Iron released from an erythrocyte lysate by oxidative stress is diffusible and in redox active form. FEBS Lett 1993 319 : 40 44.
56. Garcia JJ, Reiter RJ, Guerrero JM et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997 408 : 297 300.
57. Leaden PJ, Catalá J. Protective effect of melatonin on ascorbate-Fe2+ lipid peroxidation of polyunsaturated fatty acids in rat liver, kidney and brain microsomes: a chemiluminescence study. J Pineal Res 2005 39 : 164 169.
58. Xu J, Sun S, Wei W et al. Melatonin reduces mortality and oxidatively mediated hepatic and renal damage due to diquat treatment. J Pineal Res 2007 42 : 166 171.
59. Reiter RJ. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Front Neuroendocrinol 1995 16 : 383 415.
60. Reiter RJ, Melchiorri D, Sewerynek E et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995 18 : 1 11.
61. Cazevieille C, Safa R, Osborne NN. Melatonin protects primary cultures of rat cortical neurones from NMDA excitotoxicity and hypoxia/reoxygenation. Brain Res 1997 768 : 120 124.
62. Poliandri AH, Esquifino AI, Cano P et al. In vivo protective effect of melatonin on cadmium-induced changes in redox balance and gene expression in rat hypothalamus and anterior pituitary. J Pineal Res 2006 41 : 238 246.
63. Wang JZ, Wang ZF. Role of melatonin in Alzheimer-like neurodegeneration. Acta Pharmacol Sin 2006 27 : 41 49.
64. Rodríguez MI, Escames G, López LC et al. Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence- accelerated mice. J Pineal Res 2007 42 : 272 279.
65. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocr 2005 27 : 119 130.
66. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 1996 85 : 1 4.